Apaziquone as an intravesical therapeutic agent for urothelial non-muscle-invasive bladder cancer.
about
Anticancer Activity of Apaziquone in Oral Cancer Cells and Xenograft Model: Implications for Oral Cancer TherapyCurrent strategies in the treatment of non-muscle-invasive bladder cancer.Intravesical therapies for bladder cancer - indications and limitations.Biomedical importance of indoles.Expert review: an update in current and developing intravesical therapies for non-muscle-invasive bladder cancer.Efficacy, pharmacokinetic and pharmacodynamic evaluation of apaziquone in the treatment of non-muscle invasive bladder cancer.
P2860
Apaziquone as an intravesical therapeutic agent for urothelial non-muscle-invasive bladder cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Apaziquone as an intravesical ...... uscle-invasive bladder cancer.
@en
Apaziquone as an intravesical ...... uscle-invasive bladder cancer.
@nl
type
label
Apaziquone as an intravesical ...... uscle-invasive bladder cancer.
@en
Apaziquone as an intravesical ...... uscle-invasive bladder cancer.
@nl
prefLabel
Apaziquone as an intravesical ...... uscle-invasive bladder cancer.
@en
Apaziquone as an intravesical ...... uscle-invasive bladder cancer.
@nl
P2860
P1476
Apaziquone as an intravesical ...... uscle-invasive bladder cancer.
@en
P2093
Joseph Chin
Vladimir Yutkin
P2860
P304
P356
10.1517/13543784.2012.646081
P407
P577
2011-12-21T00:00:00Z